1. Nash MA, Edelmann CM, Bernstein J, Barnett HL. The nephrotic syndrome. In: Edelmann CM, ed. Pediatric Kidney Disease. Boston: Little, Brown and Co; 1992:1247-1267.
5. Zilleruelo G, Hsia SL, Freundlich M, et al. Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr.1984;104:61-64.
7. Marsh J, Drabkin D. Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipidemia. Metabolism. 1960;9:946-955.
8.
8. Goldberg CARK, Helena CF, Oliveria ED, et al. Increased hepatic cholesterol production due to liver hypertrophy in rat experimental nephrosis. Biochem Biophys Acta. 1982;710:71-75.
9.
9. Golper TA, Feingold KR, Fulford MF, Siperstein MD. The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat. J Lipid Res. 1986; 27:1044-1051.
10.
10. Heubi J, Lewis L. Diseases of the gallbladder in infancy, childhood, and adolescence. In: Suchy FJ, ed. Liver Disease in Children. New York: Mosby; 1994:609-621.
11.
11. Palasciano G, Portincasa P, Vinciguerra V. Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index. Am J Gastroenterol. 1989;84:1378-1382.
12.
12. Barbara I, Sama C, Labate AMM. A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology. 1987;7:913-917.
13.
13. Sanjad S, Al-Abbad A, A-Shorafa S. Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy. J Pediatr.1997;130:470-474.
